Influenza


PUBLISHED: 2018 CATEGORY: Seniors TYPE: PDFAge or chronic conditions make the flu even more dangerous

Age or chronic conditions make the flu even more dangerous

Authors: McCourt DF
Corporate Authors: Immunize Canada
Publisher: Macleans

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines

Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines

In 2017, the World Health Organization (WHO) published a document aimed at facilitating influenza vaccine introduction and use in low- and middle-income countries. The document, “The Immunological Basis for Immunization Series: Influenza Vaccines”, is freely available on the WHO website. The main purpose of this document is to give immunization managers and vaccination professionals an authoritative but easily-understood overview of the scientific basis of influenza vaccination and the immunological basis for the WHO position on influenza vaccines. The influenza vaccine document comprises one module of the WHO Immunological Basis for Immunization series. The immunization community is invited to use these references; it is hoped that the influenza vaccine module will be a valuable resource for persons who manage and monitor influenza vaccine programs, particularly in low- and middle-income countries.

Authors: Ortiz JR, Hombach J
Journal Issue: 37
Journal Title: Vaccine
Journal Volume: 36
Publisher: Elsevier

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019

Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019

The National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019 updates NACI’s recommendations regarding the use of seasonal influenza vaccines.

Corporate Authors: National Advisory Committee on Immunization
Publisher: Public Health Agency of Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Canadian Pandemic Influenza Preparedness: Communications strategy

Canadian Pandemic Influenza Preparedness: Communications strategy

This strategy is grounded in several communications guiding principles: putting the health of Canadians first; providing timely and sound information; communicating in a coordinated fashion from across all levels of government; protecting confidentiality; and monitoring and adapting to the public’s perception of risk. The Annex outlines a risk communications approach, proposes triggers for action based on pandemics of varying impact, and includes a Communication Protocol that will be used countrywide in the event of a pandemic.

Authors: Henry B
Corporate Authors: Canadian Pandemic Influenza Preparedness Task Group
Journal Title: CCDR
Journal Volume: 44-5
Publisher: Public Health Agency of Canada

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018–2019

Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018–2019

Le présent document, intitulé Comité consultatif national de l’immunisation (CCNI) : Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018-2019, met à jour les recommandations du CCNI concernant l’utilisation de vaccins antigrippaux saisonniers.

Corporate Authors: Comité consultatif national de l'immunisation
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2018 CATEGORY: Seniors, Adults TYPE: PDFFor older Canadians, the flu shot is a lifesaver

For older Canadians, the flu shot is a lifesaver

Authors: McCourt DF
Corporate Authors: Immunize Canada
Publisher: Macleans

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016

Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010–2016

In this retrospective cohort of over 2 million pregnancies that researchers assembled from 2010 to 2016 across 5 regions in 4 countries, 84% of the pregnancies overlapped with an influenza season. Thus, the risk of influenza virus infection is relevant to most pregnant women.

Authors: Thompson MG et al.
Journal Issue: 11 October 2018
Journal Title: Clinical Infectious Diseases
Publisher: Oxford Academic

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use?

Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use?

Canada and the USA differ in their recommendations for the use of live attenuated influenza vaccine (LAIV). The Canadian National Advisory Committee on Immunization (NACI) continues to recommend LAIV as one of the influenza vaccines available for use in children 2 to 17 years of age. The US Advisory Committee on Immunization Practices made an interim recommendation against the use of LAIV for the 2016-2017 influenza season in response to low LAIV effectiveness observed in the USA during the 2013-2014 to 2015-2016 seasons. The recommendation has been continued for the 2017-2018 season. In response, NACI undertook a review of available LAIV effectiveness data in children and adolescents from Canada, the USA and a number of European countries. This commentary by Canada’s Chief Public Health Officer summarizes the findings of that review and provides the rationale for Canada’s current continued recommendation for LAIV use.

Authors: Tam TWS
Journal Issue: 1
Journal Title: Paediatrics & Child Health
Journal Volume: 23
Publisher: Oxford Academic

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Les recommandations relatives aux vaccins antigrippaux administrés aux enfants et aux adolescents pour la saison 2017-2018

Les recommandations relatives aux vaccins antigrippaux administrés aux enfants et aux adolescents pour la saison 2017-2018

La Société canadienne de pédiatrie continue d’encourager la vaccination antigrippale annuelle de TOUS les enfants et les adolescents, dès l’âge de six mois. Les recommandations du Comité consultatif national de l’immunisation (CCNI) pour la saison 2017-2018 n’ont pas subi de changements importants par rapport à la saison précédente. Le CCNI a analysé toutes les données sur l’efficacité du vaccin vivant atténué contre l’influenza (VVAI) sur le marché et conclut qu’elles en appuient l’utilisation au Canada, même si les États-Unis ne le recommandent pas en raison de doutes quant à son efficacité.

Authors: Moore DL
Journal Issue: 1
Journal Title: Paediatrics & Child Health
Journal Volume: 23
Publisher: Oxford Academic

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Les recommandations relatives aux vaccins antigrippaux administrés aux enfants et aux adolescents pour la saison 2018-2019 : Point de pratique de la Société canadienne de pédiatrie

Les recommandations relatives aux vaccins antigrippaux administrés aux enfants et aux adolescents pour la saison 2018-2019 : Point de pratique de la Société canadienne de pédiatrie

La Société canadienne de pédiatrie continue d’encourager la vaccination antigrippale annuelle de tous les enfants et les adolescents, dès l’âge de six mois. Les recommandations du Comité consultatif national de l’immunisation (CCNI) pour la saison 2018-2019 n’ont pas subi de changements importants par rapport à la saison précédente. Le vaccin quadrivalent continue d’être recommandé chez les enfants âgés de six mois à 17 ans lorsqu’il est disponible. Tant le vaccin antigrippal inactivé que le vaccin vivant atténué peuvent être utilisés pour les enfants et les adolescents de deux à 17 ans qui ne sont pas immunodéprimés.

Authors: Moore DL
Corporate Authors: Société canadienne de pédiatrie, Comité des maladies infectieuses et d'immunisation
Publisher: Société canadienne de pédiatrie